Asset
Rezatapopt
PMV Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06054464 | phase1 | completed | 2023-09-19 | 2023-11-03 | PMV Pharmaceuticals, Inc | A Study to Investigate the Effects of Acid Reducing Agents on Pharmacokinetics of PC14586 in Healthy Participants |
| NCT06362642 | phase1 | completed | 2024-03-28 | 2024-10-22 | PMV Pharmaceuticals, Inc | A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of PC14586 in Healthy Participants |
| NCT05249348 | phase1 | completed | 2021-12-20 | 2022-06-09 | PMV Pharmaceuticals, Inc | Effect of Food on PC14586 in Healthy Volunteers and the PK of PC14586 in Healthy Japanese Volunteers |
FDA applications (0)
This company has no applications containing this asset.